Figure 1
Figure 1. Polyclonal EBNA1-specific IFN-γ CD8+ T cells are capable of recognizing and killing endogenously expressed EBNA1-presenting B cells. Polyclonal EBNA1-specific T cells were generated from healthy PBMCs using the 14-day peptide pool expansion protocol. On day 14, the cells were restimulated with the EBNA1 peptide pool and live sorted for IFN-γ–producing CD8+ T cells using PerCP-labeled anti–human CD8 monoclonal antibody, FITC-labeled anti–human CD14 monoclonal antibody, and PE-labeled IFN-γ detection antibody/IFN-γ catch reagent. (A) Flow cytometry live sort of IFN-γ+ CD8+ T cells and IFN-γ− CD8+ T cells. The percentage of the cells within each quadrant is shown. Cells were gated on CD14-negative lymphocyte population. (B) Five-hour 51Cr release assay comparing the sorted IFN-γ+ CD8+ T cells and IFN-γ− CD8+ T cells using autologous LCL and K562 as targets. Samples were tested in duplicate with an effector/target ratio of 20:1. Error bars represent SEM.

Polyclonal EBNA1-specific IFN-γ CD8+ T cells are capable of recognizing and killing endogenously expressed EBNA1-presenting B cells. Polyclonal EBNA1-specific T cells were generated from healthy PBMCs using the 14-day peptide pool expansion protocol. On day 14, the cells were restimulated with the EBNA1 peptide pool and live sorted for IFN-γ–producing CD8+ T cells using PerCP-labeled anti–human CD8 monoclonal antibody, FITC-labeled anti–human CD14 monoclonal antibody, and PE-labeled IFN-γ detection antibody/IFN-γ catch reagent. (A) Flow cytometry live sort of IFN-γ+ CD8+ T cells and IFN-γ CD8+ T cells. The percentage of the cells within each quadrant is shown. Cells were gated on CD14-negative lymphocyte population. (B) Five-hour 51Cr release assay comparing the sorted IFN-γ+ CD8+ T cells and IFN-γ CD8+ T cells using autologous LCL and K562 as targets. Samples were tested in duplicate with an effector/target ratio of 20:1. Error bars represent SEM.

Close Modal

or Create an Account

Close Modal
Close Modal